Be Biopharma Announces Preclinical Data for BE-102 in Hypophosphatasia

Be Biopharma presented preclinical data for BE-102, a B cell medicine, showing continuous secretion of active alkaline phosphatase (ALP) for up to six...
Home/KnloSights/Clinical Trial Updates/Be Biopharma Announces Preclinical Data for BE-102 in Hypophosphatasia